Polymorphisms of TCF7L2 gene in South Brazilian women with polycystic ovary syndrome: A Cross-sectional study

European Journal of Endocrinology

Volumn 169, Issue 5, 2013, Pages 569-576

  Ramos, Ramon Bossardi ^a   Wiltgen, Denusa ^a   Spritzer, Poli Mara ^a,b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; THYMINE; TRANSCRIPTION FACTOR 7 LIKE 2; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; BRAZIL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ETHNIC GROUP; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HIRSUTISM; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; OVARY POLYCYSTIC DISEASE; OVULATION; POPULATION DISTRIBUTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH BRAZILIAN; TCF7L2 GENE; WAIST CIRCUMFERENCE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ANTHROPOMETRY; BLOOD GLUCOSE; BRAZIL; CHOLESTEROL; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION; SAMPLE SIZE; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 84885153907     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-13-0105     Document Type: Article

References (56)

1. Berneis K, Rizzo M, Hersberger M, Rini GB, Di Fede G, Pepe I, Spinas GA & Carmina E. Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome. International Journal of Clinical Practice 2009 63 56-62. (doi:10.1111/j.1742-1241. 2008.01897.x)
2. Wild RA, Carmina E, Diamanti-Kandarakis E, Dokras A, Escobar-Morreale HF, Futterweit W Lobo R, Norman RJ, Talbott E & Dumesic DA. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society Journal of Clinical Endocrinology and Metabolism 2010 95 2038-2049. (doi:10.1210/jc.2009-2724)
3. Diamanti-Kandarakis E, Spritzer PM, Sir-Petermann T & Motta AB. Insulin resistance and polycystic ovary syndrome through life. CurrentPharmaceuticalDesign 2012 18 5569-5576. (doi:10.2174/138161212803307590)
4. Ehrmann DA. Polycystic ovary syndrome. New England Journal of Medicine 2005 352 1223-1236. (doi:10.1056/NEJMra 041536)
5. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertility and Sterility 2009 91 456-488. (doi:10.1016/j.fertnstert. 2008.06.035)
6. Norman RJ, Dewailly D, Legro RS & Hickey TE. Polycystic ovary syndrome. Lancet 2007 370 685-697. (doi:10.1016/S0140-6736 (07) 61345-2)
7. Jones MR, Chua AK, Mengesha EA, Taylor KD, Chen YD, Li X, Krauss RM, Rotter JI, Reproductive Medicine N, Legro RS et al. Metabolic and cardiovascular genes in polycystic ovary syndrome: a candidate-wide association study (CWAS). Steroids 2012 77 317-322. (doi:10.1016/j.steroids.2011.12.005)
8. Rashidi B, Azizy L, Najmeddin F & Azizi E. Prevalence of the insulin receptor substrate-1 (IRS-1) Gly972Arg and the insulin receptor substrate-2 (IRS-2) Gly105 7Asp polymorphisms in PCOS patients and non-diabetic healthy women. Journal of Assisted Reproduction and Genetics 2012 29 195-201. (doi:10.1007/s10815-011-9693-7)
9. Li Y, Liu F, Luo S, Hu H, Li XH & Li SW Polymorphism TC of gene CYP17 promoter and polycystic ovary syndrome risk: a meta-analysis. Gene 2012 495 16-22. (doi:10.1016/j.gene.2011. 12.048)
10. Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J, Helgason A, Stefansson H, Emilsson V, Helgadottir A et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nature Genetics 2006 38 320-323. (doi:10.1038/ng1732)
11. Cauchi S, Vaxillaire M, Choquet H, Durand E, Duval A, Polak M & Froguel P. No major contribution of TCF7L2 sequence variants to maturity onset of diabetes of the young (MODY) or neonatal diabetes mellitus in French white subjects. Diabetologia 2007 50 214-216. (doi:10.1007/s00125-006-0505-z)
12. Ereqat S, Nasereddin A, Cauchi S, Azmi K, Abdeen Z & Amin R. Association of a common variant in TCF7L2 gene with type 2 diabetes mellitus in the Palestinian population. Acta Diabetologica 2010 47 (Suppl 1) 195-198. (doi:10.1007/s00592-009-0161-0)
13. Barra GB, Dutra LA, Watanabe SC, Costa PG, Cruz PS, Azevedo MF & Amato AA. Association of the rs7903146 single nucleotide polymorphism at the transcription factor 7-like 2 (TCF7L2) locus with type 2 diabetes in Brazilian subjects. Arquivos Brasileiros de Endocrinologia e Metabologia 2012 56 479-484. (doi:10.1590/S0004-27302012000800003)
14. Tan S, Scherag A, Janssen OE, Hahn S, Lahner H, Dietz T, Scherag S, Grallert H, Vogel CI, Kimmig R et al. Large effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS). BMC Medical Genetics 2010 11 12. (doi:10.1186/1471-2350-11-12)
15. Yalamanchi SK, Sam S, Cardenas MO, Holaday LW, Urbanek M & Dunaif A. Association of fibrillin-3 and transcription factor-7-like 2 gene variants with metabolic phenotypes in PCOS. Obesity 2012 20 1273-1278. (doi:10.1038/oby.2011. 400)
16. Vcelak J, Vejrazkova D, Vankova M, Lukasova P, Bradnova O, Halkova T, Bestak J, Andelova K, Kvasnickova H, Hoskovcova P et al. T2D risk haplotypes of the TCF7L2 gene in the Czech population sample: the association with free fatty acids composition. Physiological Research 2012 61 229-240.
17. Wang J, Hu F, Feng T, Zhao J, Yin L, Li L, Wang Y, Wang Q & Hu D. Meta-analysis of associations between TCF7L2 polymorphisms and risk of type 2 diabetes mellitus in the Chinese population. BMC Medical Genetics 2013 14 8. (doi:10.1186/1471-2350-14-8)
18. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome. Fertility and Sterility 2004 81 19-25. (doi:10.1093/humrep/deh098)
19. Wiltgen D, Benedetto IG, Mastella LS & Spritzer PM. Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome. Human Reproduction 2009 24 1726-1731. (doi:10.1093/humrep/dep072)
20. Di Domenico K, Wiltgen D, Nickel FJ, Magalhaes JA, Moraes RS & Spritzer PM. Cardiac autonomic modulation in polycystic ovary syndrome: does the phenotype matter? Fertility and Sterility 2013 99 286-292. (doi:10.1016/j. fertnstert.2012.08.049)
21. Toscani M, Migliavacca R, Sisson de Castro JA & Spritzer PM. Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome. Metabolism: Clinical and Experimental 2007 56 992-997. (doi:10.1016/j.metabol.2007.03.006)
22. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003 42 1206-1252. (doi:10.1161/01. HYP. 0000107251.49515.c2)
23. Friedewald WT, Levy RI & Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 1972 18 499-502.
24. Kahn HS. The "lipid accumulation product" performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovascular Disorders 2005 5 26. (doi:10.1186/1471-2261-5-26)
25. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G & Quon MJ. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. Journal of Clinical Endocrinology and Metabolism 2000 85 2402-2410. (doi:10.1210/jc.85.7.2402)
26. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity Circulation 2009 120 1640-1645. (doi:10.1161/CIRCULATI0NAHA.109.192644)
27. Miller SA, Dykes DD & Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research 1988 16 1215. (doi:10.1093/nar/16.3.1215)
28. Hedrick PW. Gametic disequilibrium measures: proceed with caution. Genetics 1987 117 331-341.
29. Lewontin RC. On measures of gametic disequilibrium. Genetics 1988 120 849-852.
30. Stephens M, Smith NJ & Donnelly P. A new statistical method for haplotype reconstruction from population data. American Journal of Human Genetics 2001 68 978-989. (doi:10.1086/319501)
31. Barber TM, Bennett AJ, Groves CJ, Sovio U, Ruokonen A, Martikainen H, Pouta A, Hartikainen AL, Elliott P, Wass JA et al. Disparate genetic influences on polycystic ovary syndrome (PCOS) and type 2 diabetes revealed by a lack of association between common variants within the TCF7L2 gene and PCOS. Diabetologia 2007 50 2318-2322. (doi:10.1007/s00125-007-0804-z)
32. Biyasheva A, Legro RS, Dunaif A & Urbanek M. Evidence for association between polycystic ovary syndrome (PCOS) and TCF7L2 and glucose intolerance in women with PCOS and TCF7L2. Journal of Clinical Endocrinology and Metabolism 2009 94 2617-2625. (doi:10.1210/jc.2008-1664)
33. Xu P, Che Y, Cao Y, Wu X, Sun H, Liang F, Sun J, Ke L, Yi L & Wang Y. Polymorphisms of TCF7L2 and HHEX genes in Chinese women with polycystic ovary syndrome. Journal of Assisted Reproduction and Genetics 2010 27 23-28. (doi:10.1007/s10815-009-93 77-8)
34. Kim JJ, Choi YM, Cho YM, Hong MA, Chae SJ, Hwang KR, Hwang SS, Yoon SH & Moon SY. Polycystic ovary syndrome is not associated with polymorphisms of the TCF7L2, CDKAL1, HHEX, KCNJ11, FTO and SLC30A8 genes. Clinical Endocrinology 2012 77 439-445. (doi:10.1111/j.1365-2265.2012.04389.x)
35. Cauchi S, Nead KT, Choquet H, Horber F, Potoczna N, Balkau B, Marre M, Charpentier G, Froguel P & Meyre D. The genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studies. BMC Medical Genetics 2008 9 45. (doi:10.1186/1471-2350-9-45)
36. Florez JC, Jablonski KA, Bayley N, Pollin TI, de Bakker PI, Shuldiner AR, Knowler WC, Nathan DM & Altshuler D. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. New England Journal of Medicine 2006 355 241-250. (doi:10.1056/NEJMoa062418)
37. Sanghera DK, Nath SK, Ortega L, Gambarelli M, Kim-Howard X, Singh JR, Ralhan SK, Wander GS, Mehra NK, Mulvihill JJ et al. TCF7L2 polymorphisms are associated with type 2 diabetes in Khatri Sikhs from North India: genetic variation affects lipid levels. Annals of Human Genetics 2008 72 499-509. (doi:10.1111/j.1469-1809.2008.00443.x)
38. Huertas-Vazquez A, Plaisier C, Weissglas-Volkov D, Sinsheimer J, Canizales-Quinteros S, Cruz-Bautista I, Nikkola E, Herrera-Hernandez M, Davila-Cervantes A, Tusie-Luna T et al. TCF7L2 is associated with high serum triacylglycerol and differentially expressed in adipose tissue in families with familial combined hyperlipidaemia. Diabetologia 2008 51 62-69. (doi:10.1007/s00125-007-0850-6)
39. Warodomwichit D, Arnett DK, Kabagambe EK, Tsai MY, Hixson JE, Straka RJ, Province M, An P Lai CQ, Borecki I et al. Polyunsaturated fatty acids modulate the effect of TCF7L2 gene variants on postprandial lipemia. Journal of Nutrition 2009 139 439-446. (doi:10.3945/jn. 108.096461)
40. Povel CM, Boer JM, Reiling E & Feskens EJ. Genetic variants and the metabolic syndrome: a systematic review. Obesity Reviews 2011 12 952-967. (doi:10.1111/j.1467-789X.2011.00907.x)
41. Saxena R, Gianniny L, Burtt NP, Lyssenko V, Giuducci C, Sjogren M, Florez JC, Almgren P, Isomaa B, Orho-Melander M et al. Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes 2006 55 2890-2895. (doi:10.2337/db06-0381)
42. Loos RJ, Franks PW, Francis RW, Barroso I, Gribble FM, Savage DB, Ong KK, O'Rahilly S & Wareham NJ. TCF7L2 polymorphisms modulate proinsulin levels and β-cell function in a British Europid population. Diabetes 2007 56 1943-1947. (doi:10.233 7/db07-0055)
43. Scott LJ, Bonnycastle LL, Willer CJ, Sprau AG, Jackson AU, Narisu N, Duren WL, Chines PS, Stringham HM, Erdos MR et al. Association of transcription factor 7-like 2 (TCF7L2) variants with type 2 diabetes in a Finnish sample. Diabetes 2006 55 2649-2653. (doi:10.233 7/db06-0341)
44. Helgason A, Palsson S, Thorleifsson G, Grant SF, Emilsson V, Gunnarsdottir S, Adeyemo A, Chen Y, Chen G, Reynisdottir I et al. Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nature Genetics 2007 39 218-225. (doi:10.1038/ng1960)
45. Wang J, Kuusisto J, Vanttinen M, Kuulasmaa T, Lindstrom J, Tuomilehto J, Uusitupa M & Laakso M. Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion. Diabetologia 2007 50 1192-1200. (doi:10.1007/s00125-007-0656-6)
46. Lyssenko V, Lupi R, Marchetti P, Del Guerra S, Orho-Melander M, Almgren P, Sjogren M, Ling C, Eriksson KF, Lethagen AL et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. Journal of Clinical Investigation 2007 117 2155-2163. (doi:10.1172/JCI30706)
47. Kirchhoff K, Machicao F, Haupt A, Schafer SA, Tschritter O, Staiger H, Stefan N, Haring HU & Fritsche A. Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion. Diabetologia 2008 51 597-601. (doi:10.1007/s00125-008-0926-y)
48. McCaffery JM, Jablonski KA, Franks PW, Dagogo-Jack S, Wing RR, Knowler WC, Delahanty L, Dabelea D, Hamman R, Shuldiner AR et al. TCF7L2 polymorphism, weight loss and proinsulin: insulin ratio in the diabetes prevention program. PLoS ONE 2011 6 e21518. (doi:10.1371/journal.pone.0021518)
49. Stolerman ES, Manning AK, McAteer JB, Fox CS, Dupuis J, Meigs JB & Florez JC. TCF7L2 variants are associated with increased proinsulin/insulin ratios but not obesity traits in the Framingham Heart Study. Diabetologia 2009 52 614-620. (doi:10.1007/s00125-009-1266-2)
50. Cauchi S, Meyre D, Dina C, Choquet H, Samson C, Gallina S, Balkau B, Charpentier G, Pattou F, Stetsyuk V et al. Transcription factor TCF7L2 genetic study in the French population: expression in human b-cells and adipose tissue and strong association with type 2 diabetes. Diabetes 2006 55 2903-2908. (doi:10.2337/db06-0474)
51. Elbein SC, Chu WS, Das SK, Yao-Borengasser A, Hasstedt SJ, Wang H, Rasouli N & Kern PA. Transcription factor 7-like 2 polymorphisms and type 2 diabetes, glucose homeostasis traits and gene expression in US participants of European and African descent. Diabetologia 2007 50 1621-1630. (doi:10.1007/s00125-007-0717-x)
52. Prestwich TC & Macdougald OA. Wnt/b-catenin signaling in adipogenesis and metabolism. Current Opinion in Cell Biology 2007 19 612-617. (doi:10.1016/j.ceb.2007.09.014)
53. Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL & MacDougald OA. Inhibition of adipogenesis by Wnt signaling. Science 2000 289 950-953. (doi:10.1126/science.289.5481.950)
54. Weedon MN. The importance of TCF7L2. Diabetic Medicine 2007 24 1062-1066. (doi:10.1111/j.1464-5491.2007.02258.x)
55. Smith U. TCF7L2 and type 2 diabetes - we WNT to know. Diabetologia 2007 50 5-7. (doi:10.1007/s00125-006-0521-z)
56. Yi F, Brubaker PL & Jin T. TCF-4 mediates cell type-specific regulation of proglucagon gene expression by b-catenin and glycogen synthase kinase-3b. Journal of Biological Chemistry 2005 280 1457-1464. (doi:10.1074/jbc. M411487200)